FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anatole Besarab

Research Profile

Procedures

Chemicals & Drugs

Disorders

Devices

Phenomena

Hematocrit

Anatomy

Concepts & Ideas

Treatment Outcome

Physiology

Vascular Patency

Co-author Network

Publications

TOP 3
Lalathaksha Kumbar; Anatole Besarab
Lifting the veil: insights into vascular access options.
Steven Fishbane; Carol Francisco; Mark Kaplan; Nathan W Levin; Francesco Locatelli; Iain C Macdougall; Martha R Mayo; Krishna R Polu; Robert Provenzano; Brigitte Schiller; Andrzej Wiecek; Anatole Besarab; Adrian C Covic; Anne-Marie Duliege
Peginesatide in patients with anemia undergoing hemodialysis.
Lenar Yessayan; Gerard Zasuwa; Alexy Yessayan; Anatole Besarab; Stanley Frinak; Ankur Sandhu; Jerry Yee
Intravenous iron dextran as a component of anemia management in chronic kidney disease: a report of safety and efficacy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anatole Besarab (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lalathaksha Kumbar; Anatole Besarab
Lifting the veil: insights into vascular access options.
Clinical journal of the American Society of Nephrology : CJASN 2013;8(5):708-10.
2013: Steven Fishbane; Carol Francisco; Mark Kaplan; Nathan W Levin; Francesco Locatelli; Iain C Macdougall; Martha R Mayo; Krishna R Polu; Robert Provenzano; Brigitte Schiller; Andrzej Wiecek; Anatole Besarab; Adrian C Covic; Anne-Marie Duliege
Peginesatide in patients with anemia undergoing hemodialysis.
The New England journal of medicine 2013;368(4):307-19.
2013: Lenar Yessayan; Gerard Zasuwa; Alexy Yessayan; Anatole Besarab; Stanley Frinak; Ankur Sandhu; Jerry Yee
Intravenous iron dextran as a component of anemia management in chronic kidney disease: a report of safety and efficacy.
International journal of nephrology 2013;2013():703038.
2012: Anatole Besarab; W Kline Bolton; Allen R Nissenson; Steven J Schwab
The normal HCT trial re-revisited: what were the actual findings?
Kidney international 2012;82(2):242; author reply 242-3.
2012: Prabir Roy-Chaudhury; Donald Schon; Steven Wu; Alexander Yevzlin; Anil Agarwal; Ammar Almehmi; Anatole Besarab; Joseph V Bonventre; Amy Dwyer; Dirk M Hentschel; Michael Kraus; Ivan Maya; Timothy Pflederer; Jack Work
Academic interventional nephrology: a model for training, research, and patient care.
Clinical journal of the American Society of Nephrology : CJASN 2012;7(3):521-4.
2012: Anatole Besarab; Carol A Francisco; Edouard R Martin; Martha Mayo; Pablo E Pergola; Krishna R Polu; Brigitte Schiller; Frederick C Whittier; Raja I Zabaneh; Steven N Zeig; Anne-Marie Duliege
An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients.
BMC nephrology 2012;13():95.
2011: Anatole Besarab
Anemia and iron management.
Seminars in dialysis 2011;24(5):498-503.
2011: E Chalhoub; M D Faber; Stanley Frinak; Edward L Peterson; Anatole Besarab; Gerard Zasuwa; Jerry Yee
De novo once-monthly darbepoetin alpha treatment for the anemia of chronic kidney disease using a computerized algorithmic approach.
Clinical nephrology 2011;76(1):1-8.
2011: Anatole Besarab; Carol L Moore
Dialysis: Two for the price of one: is rt-PA ready for prime time?
Nature reviews. Nephrology 2011;7(6):310-1.
2011: Anatole Besarab; Jerry Yee
Candidate biomarkers for erythropoietin response in end-stage renal disease.
Kidney international 2011;79(5):488-90.
2011: Andrew S Bomback; James A Tumlin; Joel Baranski; James E Bourdeau; Anatole Besarab; Alice S Appel; Jai Radhakrishnan; Gerald B Appel
Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel.
Drug design, development and therapy 2011;5():147-53.
2011: Anatole Besarab; Rahul Pandey
Catheter management in hemodialysis patients: delivering adequate flow.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(1):227-34.
2010: Anatole Besarab; Daniel W Coyne
Iron supplementation to treat anemia in patients with chronic kidney disease.
Nature reviews. Nephrology 2010;6(12):699-710.
2010: Fernando Carrera; Charmaine E Lok; Angel de Francisco; Francesco Locatelli; Johannes F E Mann; Bernard CANAUD; Peter G Kerr; Iain C Macdougall; Anatole Besarab; Giuseppe Villa; Isabelle Kazes; Bruno van Vlem; Shivinder Jolly; Ulrich Beyer; Frank C Dougherty
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(12):4009-17.
2010: Gerard Zasuwa; Stanley Frinak; Anatole Besarab; Edward L Peterson; Jerry Yee
Automated intravascular access pressure surveillance reduces thrombosis rates.
Seminars in dialysis 2010;23(5):527-35.
2010: Kenneth Abreo; Michael Allon; Arif Asif; Naveen Atray; Anatole Besarab; Laura M Dember; Bradley S Dixon; Maria DeVita; James Kaufman; Brian M Murray; Vo D Nguyen; William D Paulson; Sunanda J Ram; Tushar Vachharajani; Thomas M Vesely; John Jason White; Jack Work; John Kennedy
Which direction is right for vascular access surveillance? A debate.
Nephrology news & issues 2010;24(7):30, 32, 34.
2010: Ankur Sandhu; Sandeep Soman; Michael Hudson; Anatole Besarab
Managing anemia in patients with chronic heart failure: what do we know?
Vascular health and risk management 2010;6():237-52.
2009: Kannaiyan S Rabindranath; Tarun Kumar Bansal; James Adams; Ruma Das; Ranjit Shail; Alison MacLeod; Carol Moore; Anatole Besarab
Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(12):3763-74.
2009: Neil C Boudville; Ognjenka Djurdjev; Iain C Macdougall; Angel L M de Francisco; Gilbert Deray; Anatole Besarab; Paul E Stevens; Rowan G Walker; Pablo Ureña; Pablo Iñigo; Roberto Minutolo; Yosef S Haviv; Karen Yeates; Marisa L Agüera; Jennifer M MacRae; Adeera Levin
Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(7):1176-82.
2009: Anatole Besarab; Stanley Frinak; Jerry Yee
What is so bad about a hemoglobin level of 12 to 13 g/dL for chronic kidney disease patients anyway?
Advances in chronic kidney disease 2009;16(2):131-42.
2009: Jerry Yee; Gerard Zasuwa; Stanley Frinak; Anatole Besarab
Hemoglobin variability and hyporesponsiveness: much ado about something or nothing?
Advances in chronic kidney disease 2009;16(2):83-93.
2009: Anatole Besarab; Walter Hermann Hörl; Donald Silverberg
Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome.
The oncologist 2009;14 Suppl 1():22-33.
2008: Anton N Sidawy; Lawrence M Spergel; Anatole Besarab; Michael Allon; William C Jennings; Frank T Padberg; M Hassan Murad; Victor Montori; Ann o'hare; Keith D Calligaro; Robyn A Macsata; Alan B Lumsden; Enrico Ascher
The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access.
Journal of vascular surgery 2008;48(5 Suppl):2S-25S.
2008: Anatole Besarab
Resolved: Fistulas are preferred to grafts as initial vascular access for dialysis. Pro.
Journal of the American Society of Nephrology : JASN 2008;19(9):1629-31.
2008: Ryan D Kilpatrick; Cathy W Critchlow; Steven Fishbane; Anatole Besarab; Catherine Stehman-Breen; Mahesh Krishnan; Brian D Bradbury
Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(4):1077-83.
2008: Richard Amerling; Anatole Besarab; CINDY ROY
New developments in anemia management in chronic kidney disease.
Nephrology news & issues 2008;22(3):suppl 1-8.
2008: Anatole Besarab; David A Goodkin; Allen R Nissenson
The normal hematocrit study--follow-up.
The New England journal of medicine 2008;358(4):433-4.
2007: Marian Klinger; Manual Arias; Vassilis Vargemezis; Anatole Besarab; Wladyslaw Sulowicz; Trevor Gerntholtz; Kazimierz Ciechanowski; Frank C Dougherty; Ulrich Beyer
Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;50(6):989-1000.
2007: Anatole Besarab; Pietro Ravani; Lawrence M Spergel; Prabir Roy-Chaudhury; Arif Asif
The native arteriovenous fistula in 2007. Research needs.
Journal of nephrology 2007;20(6):668-73.
2007: Anatole Besarab; Arif Asif; Prabir Roy-Chaudhury; Lawrence M Spergel; Pietro Ravani
The native arteriovenous fistula in 2007. Surveillance and monitoring.
Journal of nephrology 2007;20(6):656-67.
2007: Steven Fishbane; Anatole Besarab
Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(6):1274-82.
2007: Arif Asif; Anatole Besarab; Prabir Roy-Chaudhury; Lawrence M Spergel; Pietro Ravani
Interventional nephrology: from episodic to coordinated vascular access care.
Journal of nephrology 2007;20(4):399-405.
2007: Lawrence M Spergel; Pietro Ravani; Prabir Roy-Chaudhury; Arif Asif; Anatole Besarab
Surgical salvage of the autogenous arteriovenous fistula (AVF).
Journal of nephrology 2007;20(4):388-98.
2007: Arif Asif; Pietro Ravani; Prabir Roy-Chaudhury; Lawrence M Spergel; Anatole Besarab
Vascular mapping techniques: advantages and disadvantages.
Journal of nephrology 2007;20(3):299-303.
2007: Lawrence M Spergel; Pietro Ravani; Arif Asif; Prabir Roy-Chaudhury; Anatole Besarab
Autogenous arteriovenous fistula options.
Journal of nephrology 2007;20(3):288-98.
2007: R Provenzano; Anatole Besarab; Iain C Macdougall; David H Ellison; A P Maxwell; W Sulowicz; Marian Klinger; B Rutkowski; R Correa-Rotter; Frank C Dougherty
The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Clinical nephrology 2007;67(5):306-17.
2007: Anatole Besarab; Moro O Salifu; N Martin Lunde; Vinod Bansal; Steven Fishbane; Frank C Dougherty; Ulrich Beyer
Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
Clinical therapeutics 2007;29(4):626-39.
2007: Prabir Roy-Chaudhury; Lawrence M Spergel; Anatole Besarab; Arif Asif; Pietro Ravani
Biology of arteriovenous fistula failure.
Journal of nephrology 2007;20(2):150-63.
2007: Pietro Ravani; Lawrence M Spergel; Arif Asif; Prabir Roy-Chaudhury; Anatole Besarab
Clinical epidemiology of arteriovenous fistula in 2007.
Journal of nephrology 2007;20(2):141-9.
2007: Ashwani Gupta; Anatole Besarab
A distributed lag model with first order auto-regressive error term for hemoglobin response to erythropoietin in dialysis patients.
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium 2007;():967.
2006: Arif Asif; Anatole Besarab; Florin Gadalean; Donna Merrill; Anne E Rismeyer; Gabriel Contreras; Baudouin Leclercq; Oliver Lenz; Jeffery Wallach; Joshua Wallach; Michael I Levine
Utility of static pressure ratio recording during angioplasty of arteriovenous graft stenosis.
Seminars in dialysis 2006;19(6):551-6.
2006: Uday S Nori; Anup Manoharan; Jerry Yee; Anatole Besarab
Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2006;48(4):596-605.
2006: Anatole Besarab
More than a decade of experience and still no consensus: controversies in iron therapy.
Clinical journal of the American Society of Nephrology : CJASN 2006;1 Suppl 1():S1-3.
2006: Anatole Besarab; Lesley Dinwiddie
Changes noted to KDOQI guidelines for vascular access.
Nephrology news & issues 2006;20(9):36.
2006: Carol Manierski; Anatole Besarab
Antimicrobial locks: putting the lock on catheter infections.
Advances in chronic kidney disease 2006;13(3):245-58.
2006: Anatole Besarab
Resolving the paradigm crisis in intravenous iron and erythropoietin management.
Kidney international. Supplement 2006;(101):S13-8.
2006: Nizar Attallah; Yahya Osman-Malik; Stanley Frinak; Anatole Besarab
Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2006;47(4):644-54.
2006: Rajiv Agarwal; Adel R Rizkala; Bahar Bastani; Marwan O Kaskas; David J Leehey; Anatole Besarab
A randomized controlled trial of oral versus intravenous iron in chronic kidney disease.
American journal of nephrology 2006;26(5):445-54.
2006: Anatole Besarab
Access monitoring is worthwhile and valuable.
Blood purification 2006;24(1):77-89.
2005: Anatole Besarab; Sandeep Soman
Does full versus partial correction of anemia have additional cardiac benefit in incident hemodialysis patients?
Nature clinical practice. Nephrology 2005;1(2):70-1.
2005: Anatole Besarab
Optimizing anaemia management with subcutaneous administration of epoetin.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20 Suppl 6():vi10-5.
2005: Anatole Besarab; Sandeep Soman
Anemia management in chronic heart failure: lessons learnt from chronic kidney disease.
Kidney & blood pressure research 2005;28(5-6):363-71.
2004: Hugh C Rayner; Anatole Besarab; Wendy W Brown; Alex Disney; Akira Saito; Ronald L Pisoni
Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(5 Suppl 2):22-6.
2004: Prakas T D'Cunha; Anatole Besarab
Vascular access for hemodialysis: 2004 and beyond.
Current opinion in nephrology and hypertension 2004;13(6):623-9.
2004: Junaid Ahmed; Anatole Besarab; Tom Lubkowski; Stanley Frinak
Effect of differing blood lines on delivered blood flow during hemodialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(3):498-508.
2004: Anatole Besarab; Deborah Brouwer
Improving arteriovenous fistula construction: fistula first initiative.
Hemodialysis international. International Symposium on Home Hemodialysis 2004;8(3):199-206.
2004: Anatole Besarab
Vascular access: issues and management.
Contributions to nephrology 2004;142():29-46.
2004: Anatole Besarab
What common practices in dialysis units can be altered to improve patient care?
Seminars in dialysis 2004;17(1):16-7.
2003: Donal N Reddan; Diane L Frankenfield; Preston S Klassen; Joseph A Coladonato; Lynda A Szczech; Curtis A Johnson; Anatole Besarab; Michael Rocco; William McClellan; Jay B Wish; William F Owen Jr
Regional variability in anaemia management and haemoglobin in the US.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(1):147-52.
2002: Jerry Yee; Anatole Besarab
Iron sucrose: the oldest iron therapy becomes new.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(6):1111-21.
2002: Stanley Frinak; Gerard Zasuwa; Thomas Dunfee; Anatole Besarab; Jerry Yee
Dynamic venous access pressure ratio test for hemodialysis access monitoring.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(4):760-8.
2002: Anatole Besarab; Carolina M Reyes; John Hornberger
Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(3):439-46.
2002: Anton N Sidawy; Richard Gray; Anatole Besarab; Mitchell Henry; Enrico Ascher; Michael Silva; Arnold Miller; Larry A Scher; Scott Trerotola; Roger T Gregory; Robert B Rutherford; K Kent
Recommended standards for reports dealing with arteriovenous hemodialysis accesses.
Journal of vascular surgery 2002;35(3):603-10.
2002: Anatole Besarab
How can the cardiac death rate be reduced in dialysis patients?
Seminars in dialysis 2002;15(1):24-6.
2002: Anatole Besarab
Preventing vascular access dysfunction: which policy to follow.
Blood purification 2002;20(1):26-35.
2001: Anatole Besarab
Evaluating iron sufficiency: a clearer view.
Kidney international 2001;60(6):2412-4.
2001: Anatole Besarab
Intervention for intra-access stenosis.
Seminars in dialysis 2001;14(5):401-2.
2001: Anatole Besarab; Tom Lubkowski; A Vu; A Aslam; Stanley Frinak
Effects of systemic hemodynamics on flow within vascular accesses used for hemodialysis.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2001;47(5):501-6.
2001: Anatole Besarab; C L Dalton
Maintaining higher TSATs and other iron indices is beneficial in management of anemic hemodialysis patients.
Nephrology nursing journal : journal of the American Nephrology Nurses' Association 2001;28(4):429-34.
2001: Anatole Besarab; M Aslam
Should the hematocrit (hemoglobin) be normalized in Pre-ESRD or dialysis patients? Yes!
Blood purification 2001;19(2):168-74.
2000: Anatole Besarab; A Levin
Defining a renal anemia management period.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000;36(6 Suppl 3):S13-23.
2000: Anatole Besarab; M Adams; S Amatucci; D Bowe; J Deane; K Ketchen; K Reynolds; A Tello
Unraveling the realities of vascular access: the Network 11 experience.
Advances in renal replacement therapy 2000;7(4 Suppl 1):S65-70.
2000: Anatole Besarab
Physiological and pharmacodynamic considerations for route of EPO administration.
Seminars in nephrology 2000;20(4):364-74.
2000: Anatole Besarab; Neeta B Amin; M Ahsan; S E Vogel; G Zazuwa; Stanley Frinak; J J Zazra; JV Anandan; A Gupta
Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients.
Journal of the American Society of Nephrology : JASN 2000;11(3):530-8.
2000: Anatole Besarab
Advances in end-stage renal diseases 2000. Access monitoring methods.
Blood purification 2000;18(4):255-9.
1999: Anatole Besarab
Iron and cardiac disease in the end-stage renal disease setting.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(4 Suppl 2):S18-24.
1999: Anatole Besarab; FS Escobar
Interventional radiologists important to vascular access management.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(4):790-2.
1999: Anatole Besarab; Stanley Frinak; Jerry Yee
An indistinct balance: the safety and efficacy of parenteral iron therapy.
Journal of the American Society of Nephrology : JASN 1999;10(9):2029-43.
1999: Anatole Besarab; W Kline Bolton; A R Nissenson; S J Schwab; D A Goodkin
The Normal Haematocrit Trial in dialysis patients with cardiac disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(8):2043-4.
1999: Anatole Besarab; J W Kaiser; Stanley Frinak
A study of parenteral iron regimens in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(1):21-8.
1999: A Gupta; Neeta B Amin; Anatole Besarab; S E Vogel; George Divine; Jerry Yee; JV Anandan
Dialysate iron therapy: infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis.
Kidney international 1999;55(5):1891-8.
1999: Anatole Besarab; FS Escobar
A glimmer of hope: increasing the construction and maturation of autologous arteriovenous fistulas.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;33(5):977-9.
1999: Jay B Wish; J Roberts; Anatole Besarab; W F Owen
The cost of implementing the Dialysis Outcomes Quality Initiative Clinical Practice Guidelines.
Advances in renal replacement therapy 1999;6(1):67-74.
1998: Anatole Besarab; W K Bolton; Jeffrey K Browne; Joan C Egrie; A R Nissenson; D M Okamoto; S J Schwab; D A Goodkin
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.
The New England journal of medicine 1998;339(9):584-90.
1998: Anatole Besarab; Stanley Frinak; Richard A Sherman; J Goldman; Francis Dumler; M V Devita; Toros Kapoian; F Al-Saghir; Tom Lubkowski
Simplified measurement of intra-access pressure.
Journal of the American Society of Nephrology : JASN 1998;9(2):284-9.
1998: Anatole Besarab; Stanley Frinak
The prevention of access failure: pressure monitoring.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1998;44(1):35-7.
1997: Anatole Besarab; Tom Lubkowski; Stanley Frinak; S Ramanathan; FS Escobar
Detection of access strictures and outlet stenoses in vascular accesses. Which test is best?
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1997;43(5):M543-7.
1997: Anatole Besarab; Tom Lubkowski; Stanley Frinak; S Ramanathan; FS Escobar
Detecting vascular access dysfunction.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1997;43(5):M539-43.
1997: A R Nissenson; Anatole Besarab; W Kline Bolton; D A Goodkin; S J Schwab
Target haematocrit during erythropoietin therapy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(9):1813-6.
1997: Anatole Besarab; R Ross; Stanley Frinak; Gerard Zasuwa
Increased urea kinetic modeling volume. Possible mechanisms and its significance.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1997;43(4):303-10.
1997: Kevin L Sullivan; Anatole Besarab
Hemodynamic screening and early percutaneous intervention reduce hemodialysis access thrombosis and increase graft longevity.
Journal of vascular and interventional radiology : JVIR 1997;8(2):163-70.
1997: A J Erslev; Anatole Besarab
Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure.
Kidney international 1997;51(3):622-30.
1997: Anatole Besarab; R Sherman
The relationship of recirculation to access blood flow.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;29(2):223-9.
1997: R A Sherman; Anatole Besarab; Steve J Schwab; Gerald A Beathard
Recognition of the failing vascular access: a current perspective.
Seminars in dialysis 1997;10(1):1-4.
1996: Anatole Besarab; D Samarapungavan
Measuring the adequacy of hemodialysis access.
Current opinion in nephrology and hypertension 1996;5(6):527-31.
1996: Anatole Besarab; F al-Saghir; N Alnabhan; Tom Lubkowski; Stanley Frinak
Simplified measurement of intra-access pressure.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1996;42(5):M682-7.
1995: A J Erslev; Anatole Besarab
The rate and control of baseline red cell production in hematologically stable patients with uremia.
The Journal of laboratory and clinical medicine 1995;126(3):283-6.
1995: Anatole Besarab; Kevin L Sullivan; R P Ross; Michael J Moritz
Utility of intra-access pressure monitoring in detecting and correcting venous outlet stenoses prior to thrombosis.
Kidney international 1995;47(5):1364-73.
1995: Anatole Besarab; R P Ross; T J Nasca
The use of recombinant human erythropoietin in predialysis patients.
Current opinion in nephrology and hypertension 1995;4(2):155-61.
1994: R P Ross; J B McCrea; Anatole Besarab
Erythropoietin response to blood loss in hemodialysis patients in blunted but preserved.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1994;40(3):M880-5.
1993: Anatole Besarab
Optimizing epoetin therapy in end-stage renal disease: the case for subcutaneous administration.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;22(2 Suppl 1):13-22.
1993: Anatole Besarab; T DeLucia; N Picarello; Donald Jungkind
Formaldehyde, sodium hypochlorite, and metabisulphite are equally effective as sterilants for central delivery systems.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1993;39(3):M590-5.
1993: Anatole Besarab; A J Erslev
Recombinant erythropoietin. The effect of the marketplace on socialized patient care.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1993;39(2):85-6.
1993: J B McCrea; G F Francos; James F Burke; H J Michael; Anatole Besarab
The beneficial effects of isradipine on renal hemodynamics in cyclosporine-treated renal transplant recipients.
Transplantation 1993;55(3):672-4.
1993: Kevin L Sullivan; Anatole Besarab; Joseph Bonn; M J Shapiro; Geoffrey A Gardiner; Michael J Moritz
Hemodynamics of failing dialysis grafts.
Radiology 1993;186(3):867-72.
1993: Anatole Besarab; J B McCrea
Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1993;39(1):11-8.
1992: Anatole Besarab; M Moritz; K Sullivan; S Dorrell; J J Price
Venous access pressures and the detection of intra-access stenosis.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1992;38(3):M519-23.
1992: Kevin L Sullivan; Anatole Besarab; S Dorrell; Michael J Moritz
The relationship between dialysis graft pressure and stenosis.
Investigative radiology 1992;27(5):352-5.
1992: Anatole Besarab; K K Flaharty; A J Erslev; J B McCrea; P H Vlasses; F Medina; Jaime Caro; E Morris
Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: the case for subcutaneous administration.
Journal of the American Society of Nephrology : JASN 1992;2(9):1405-16.
1991: G C Francos; Y C Kauh; S D Gittlen; E S Schulman; Anatole Besarab; S Goyal; James F Burke
Elevated plasma histamine in chronic uremia. Effects of ketotifen on pruritus.
International journal of dermatology 1991;30(12):884-9.
1991: Anatole Besarab; T A Golper
Response of continuous peritoneal dialysis patients to subcutaneous recombinant human erythropoietin differs from that of hemodialysis patients.
ASAIO transactions / American Society for Artificial Internal Organs 1991;37(3):M395-6.
1991: Anatole Besarab; S Dorrell; M Moritz; H Michael; K Sullivan
Determinants of measured dialysis venous pressure and its relationship to true intra-access venous pressure.
ASAIO transactions / American Society for Artificial Internal Organs 1991;37(3):M270-1.
1991: Anatole Besarab; F M Besarab; D Miller
Effects of dialysis factors and route of administration on response of hemodialysis patients to recombinant human erythropoietin.
ASAIO transactions / American Society for Artificial Internal Organs 1991;37(3):M181-2.
1991: C S Ben-Maimon; James F Burke; Anatole Besarab; Bruce Jarrell; G C Francos; S S Moyer
Evidence against chronic progressive cyclosporine nephrotoxicity.
Transplantation proceedings 1991;23(1 Pt 2):1260-2.
1990: Anatole Besarab; F Medina; E Musial; N Picarello; H Michael
Recombinant human erythropoietin does not increase clotting in vascular accesses.
ASAIO transactions / American Society for Artificial Internal Organs 1990;36(3):M749-53.
1990: Anatole Besarab
Recombinant human erythropoietin: physiology, pathophysiology of anemia in renal failure, and economic aspects related to dosing.
American journal of nephrology 1990;10 Suppl 2():2-6.
1989: H J Michael; G C Francos; James F Burke; Anatole Besarab; M Moritz; D Gillum; Bruce Jarrell
A comparison of the effects of cyclosporine versus antilymphocyte globulin on delayed graft function in cadaver renal transplant recipients.
Transplantation 1989;48(5):805-8.
1989: A M Grimm; K K Flaharty; L E Hopkins; J Mauskopf; Anatole Besarab; P H Vlasses
Economics of epoetin therapy.
Clinical pharmacy 1989;8(11):807-10.
1988: Anatole Besarab; Bruce Jarrell; James F Burke; G Francos; Jaime Caro; E Mallon
"Erythrocytosis" in renal transplantation patients treated with cyclosporine.
Transplantation proceedings 1988;20(3 Suppl 3):945-7.
1988: G C Francos; James F Burke; Anatole Besarab; Bruce Jarrell; M J Marcolina; E Mallon
New insights into the mechanisms of post-transplant erythrocytosis.
Transplantation proceedings 1988;20(1 Suppl 1):449-52.
1987: Anatole Besarab; Jaime Caro; Bruce Jarrell; G Francos; A J Erslev
Dynamics of erythropoiesis following renal transplantation.
Kidney international 1987;32(4):526-36.
1987: Anatole Besarab; Bruce Jarrell; S Hirsch; R Anthony Carabasi; M D Cressman; P Green
Use of the isolated perfused kidney model to assess the acute pharmacologic effects of cyclosporine and its vehicle, cremophor EL.
Transplantation 1987;44(2):195-201.
1987: S Hirsch; Anatole Besarab; Bruce Jarrell; R Anthony Carabasi; M D Cressman; P Green
Acute nephrotoxicity following intravenous cyclosporine.
Transplantation proceedings 1987;19(1 Pt 2):1387-90.
1987: P H Vlasses; Anatole Besarab; S R Lottes; D P Conner; P J Green; M H Gault
False-positive digoxin measurements due to conjugated metabolite accumulation in combined renal and hepatic dysfunction.
American journal of nephrology 1987;7(5):355-9.
1986: Patricio Reyes; C F Gonzalez; M K Zalewska; Anatole Besarab
Intracranial calcification in adults with chronic lead exposure.
AJR. American journal of roentgenology 1986;146(2):267-70.
1985: Anatole Besarab; Jaime Caro; Bruce Jarrell; J Burke; G Francos; E Mallon; R Karsch
Effect of cyclosporine and delayed graft function on posttransplantation erythropoiesis.
Transplantation 1985;40(6):624-31.
1985: G C Francos; Anatole Besarab; James F Burke; J Peters; M V Tahamont; M H Gee; J T Flynn; D Gzesh
Dialysis-induced hypoxemia: membrane dependent and membrane independent causes.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1985;5(3):191-8.
1985: A J Erslev; J Caro; Anatole Besarab
Why the kidney?
Nephron 1985;41(3):213-6.
1984: Anatole Besarab; J W Swanson
Tachyphylaxis to PTH in the isolated perfused rat kidney: resistance of anticalciuria.
The American journal of physiology 1984;247(2 Pt 2):F240-5.
1984: Bruce Jarrell; Anatole Besarab; James F Burke; R Karsch; S Yang; E Mallon
Effect of antilymphoblast globulin on Coombs' reactions.
Transplantation 1984;37(6):621-3.
1984: Anatole Besarab; G B Martin; T Mead; Bruce Jarrell; L Wesson
Effect of plasma proteins and buffer in flushing solutions on rat kidney preservation by cold storage.
Transplantation 1984;37(3):239-45.
1984: G C Francos; Anatole Besarab; R E Joseph
Disorders of oesophageal motility in chronic haemodialysis patients.
Lancet 1984;1(8370):219.
1983: Anatole Besarab; L Wesson; Bruce Jarrell; J F Burke
Effect of delayed graft function and ALG on the circaseptan (about 7-day) rhythm of human renal allograft rejection.
Transplantation 1983;35(6):562-6.
1983: G C Francos; J F Burke; Anatole Besarab; J Martinez; R G Kirkwood; L A Hummel
An unsuspected cause of acute hemolysis during hemodialysis.
Transactions - American Society for Artificial Internal Organs 1983;29():140-5.
1983: Anatole Besarab; B U Ihle; Bruce Jarrell; J F Burke; L G Wesson
Some effects of preservation and acute renal failure on function and proteinuria of renal transplants.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1983;2(4):456-63.
1982: Anatole Besarab; Bruce Jarrell; B U Ihle; J E Colberg; J F Burke; L Wesson
Adverse effects of prophylactic irradiation and acute tubular necrosis on renal graft function and survival.
Nephron 1982;31(4):347-53.
1982: Anatole Besarab; J W Swanson
Differences in effects of amino-terminal and intact parathyroid hormone on calcium, phosphate, and cAMP excretion by the isolated perfused rat kidney.
Renal physiology 1982;5(6):261-71.
1982: Anatole Besarab; P Pomerantz; J W Swanson
Effect of exogenous adenosine 3':5'-cyclic monophosphate, parathyroid hormone and acetazolamide on electrolyte hormone and acetazolamide on electrolyte excretion by the isolated perfused rat kidney.
Renal physiology 1982;5(3):124-35.
1981: Anatole Besarab; J F Caro
Increased absolute calcium binding to albumin in hypoalbuminaemia.
Journal of clinical pathology 1981;34(12):1368-74.
1981: Anatole Besarab; A DeGuzman; J W Swanson
Effect of albumin and free calcium concentrations on calcium binding in vitro.
Journal of clinical pathology 1981;34(12):1361-7.
1981: Anatole Besarab; Bruce Jarrell; B U Ihle; L Wesson; J E Colberg
Diagnostic and prognostic significance of an increase in fractional protein clearance ratio before and during rejection of renal transplant.
Transplantation 1981;32(6):508-11.
1981: J W Swanson; Anatole Besarab; P P Pomerantz; A DeGuzman
Effect of erythrocytes and globulin on renal functions of the isolated rat kidney.
The American journal of physiology 1981;241(2):F139-50.
1981: Anatole Besarab; J F Caro; B U Ihle; J F Burke; J A Glennon; J A Fischer
Suppression of secondary hyperparathyroidism by propranolol in renal failure patients.
Nephron 1981;27(3):127-33.
1979: P Silva; L Landsberg; Anatole Besarab
Excretion and metabolism of catecholamines by the isolated perfused rat kidney.
The Journal of clinical investigation 1979;64(3):850-7.
1979: J F Caro; Anatole Besarab; J T Flynn
Prostaglandin E and hypercalcemia in breast carcinoma: only a tumor marker? A need for perspective.
The American journal of medicine 1979;66(2):337-41.
1978: J F Caro; Anatole Besarab; J A Glennon
Symptomatic hypocalcemia following combined calcitonin and mithramycin therapy for hypercalcemia due to malignancy.
Cancer treatment reports 1978;62(10):1561-3.
1978: J F Caro; Anatole Besarab; J F Burke; J A Glennon
A possible role for propranolol in the treatment of renal osteodystrophy.
Lancet 1978;2(8087):451-4.
1978: Anatole Besarab; J F Caro
Mechanisms of hypercalcemia in malignancy.
Cancer 1978;41(6):2276-85.
1978: J F Caro; Anatole Besarab
Propranolol therapy for hyperparathyroidism?
Lancet 1978;1(8068):827.
1977: Anatole Besarab; P Silva; L Landsberg; F H Epstein
Effect of catecholamines on tubular function in the isolated perfused rat kidney.
The American journal of physiology 1977;233(1):F39-45.
1977: C F Schiffer; J F Burke; Anatole Besarab; N Lasker; M L Simenhoff
Amylase/creatinine clearance fraction in patients on chronic hemodialysis.
Annals of internal medicine 1977;86(1):65-6.
1976: Anatole Besarab; P Silva; F H Epstein
Multiple pumps for sodium reabsorption by the perfused kidney.
Kidney international 1976;10(2):147-53.
1976: Anatole Besarab; R S Brown; N T Rubin; E Salzman; L Wirthlin; T Steinman; R R Atlia; J J Skillman
Reversible renal failure following bilateral renal artery occlusive disease. Clinical features, pathology, and the role of surgical revascularization.
JAMA : the journal of the American Medical Association 1976;235(26):2838-41.
1975: P Silva; B D Ross; A N Charney; Anatole Besarab; F H Epstein
Potassium transport by the isolated perfused kidney.
The Journal of clinical investigation 1975;56(4):862-9.
1975: Anatole Besarab; P Silva; B Ross; F H Epstein
Bicarbonate and sodium reabsorption by the isolated perfused kidney.
The American journal of physiology 1975;228(5):1525-30.
1974: A N Charney; P Silva; Anatole Besarab; F H Epstein
Separate effects of aldosterone, DOCA, and methylprednisolone on renal Na-K-ATPase,.
The American journal of physiology 1974;227(2):345-50.
1973: J E Allen; D B Goodman; Anatole Besarab; Howard Rasmussen
Studies on the biochemical basis of oxygen toxicity.
Biochimica et biophysica acta 1973;320(3):708-28.
1970: Anatole Besarab; M Litt
Model studies on the adhesive properties of mucus and similar polymer solutions.
Archives of internal medicine 1970;126(3):504-7.